These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 2128003)
1. Prognosis of acute lymphoblastic leukaemia in Ibadan, Nigeria. Okpala IE; Olatunji PO; Okunade MA; Ogunsanwo BA; Jeje OM; Shokunbi WA; Essien EM Afr J Med Med Sci; 1990 Dec; 19(4):313-7. PubMed ID: 2128003 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055 [TBL] [Abstract][Full Text] [Related]
4. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284 [TBL] [Abstract][Full Text] [Related]
5. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669 [TBL] [Abstract][Full Text] [Related]
6. [Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol]. Ribera JM; Grañena A; Sierra J; Urbano-Ispizua A; Brugués R; Rozman C Med Clin (Barc); 1988 Nov; 91(17):653-7. PubMed ID: 3230971 [No Abstract] [Full Text] [Related]
7. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity. Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624 [TBL] [Abstract][Full Text] [Related]
8. Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. Biondi A; Rizzari C; Valsecchi MG; De Lorenzo P; Aricò M; Basso G; Locatelli F; Lo Nigro L; De Rossi G; Masera G Haematologica; 2006 Apr; 91(4):534-7. PubMed ID: 16537119 [TBL] [Abstract][Full Text] [Related]
9. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]. Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693 [TBL] [Abstract][Full Text] [Related]
10. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors. Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717 [TBL] [Abstract][Full Text] [Related]
11. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E; Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center]. Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem]. Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412 [No Abstract] [Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
15. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia. Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428 [TBL] [Abstract][Full Text] [Related]
16. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Büyükçelik A; Yalçin B; Utkan G; Doruk H Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922 [No Abstract] [Full Text] [Related]
17. Acute myeloid and lymphoblastic leukemia in adults. The course of the disease in 315 patients from one region, during a ten-year period. Johnsen HE; Bergmann OJ; Ellegaard J; Bastrup-Madsen P Dan Med Bull; 1989 Apr; 36(2):189-93. PubMed ID: 2707057 [TBL] [Abstract][Full Text] [Related]
18. [Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?]. Schrøder H; Kjeldstad M; Boesen AM; Nielsen OJ; Schmidt KG; Johnsen HE; Gregersen H; Gustafsson G Ugeskr Laeger; 2006 Jun; 168(26-32):2554-8. PubMed ID: 16824410 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546 [TBL] [Abstract][Full Text] [Related]
20. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]